BIOMAT Database Logo BIOMAT Database Logo

Oral anticoagulants: old drugs with a promising future. 1995

A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Servizio di Coagulazione, Istituto Scientifico S. Raffaele, Milano, Italy.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Newer oral anticoagulants: a promising future.
April 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Laccases: old enzymes with a promising future.
March 2015, Cellular and molecular life sciences : CMLS,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Interactions of oral anticoagulants with other drugs.
December 1967, The Medical letter on drugs and therapeutics,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Nicotinic acid: an old drug with a promising future.
March 2008, British journal of pharmacology,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
[Drugs interacting with coumarine oral anticoagulants (author's transl)].
November 1973, Klinische Wochenschrift,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?
June 2015, Seminars in thrombosis and hemostasis,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
[Present and future of oral anticoagulants].
January 2000, Medicina,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
[Cardiovascular drugs. 11/12. Oral anticoagulants].
April 2005, Soins; la revue de reference infirmiere,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Cardioversion with novel oral anticoagulants: reconfirming a 50-year-old standard.
March 2014, Journal of the American College of Cardiology,
A D'Angelo, and L Crippa, and A Agazzi, and P Della Valle, and N Anzalone, and A M Garlando, and S V D'Angelo
Anti-chemokine small molecule drugs: a promising future?
March 2010, Expert opinion on investigational drugs,
Copied contents to your clipboard!